Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and by patients at home under physician supervision. In February 2012, it acquired Synovis Life Technologies, Inc. In November 2011, it acquired Baxa Corporation. In April 2012, it purchased SIGMA International General Medical Apparatus, LLC.
|Headquarters||One Baxter Parkway|
DEERFIELD, IL, United States 60015-4625
|Chairman of the Board, Chief Executive Officer||Robert Parkinson|
|Chief Financial Officer, Corporate Vice President||Robert Hombach|
|Corporate Vice President, General Counsel||David Scharf|
|Corporate Vice President, Controller||Sebastian Bufalino|
|Corporate Vice President - Human Resources||Jeanne Mason|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||542.0M||Book Value||$12.70|
|Annual Dividend Rate||$1.96||Price/Sales (TTM)||2.8|
|Ex-Div Date||6/5/13||P/Cash Flow (TTM)||12.9x|
|Pay Date||6/5/13||Operating Margin||19.98%|
*GAAP = prior to non-GAAP analyst adjusted earnings.